To the editor:
The human proteins rabenosyn-5 and VPS45 form a complex that plays a key role in early endocytosis [1] [2] [3] [4] . Pathogenic variants in VPS45 cause severe congenital neutropenia (SCN) with impaired neutrophil function, reticulin fibrosis of the bone marrow, and extramedullary hematopoiesis (OMIM: 615285) [5] [6] [7] [8] .
Patients with a specific VPS45 variant (p.Glu238Lys) also have intellectual disability and bilateral optic nerve hypoplasia 5, 6 . To date, the only evidence of a potential role for RBSN in human disease is the report of a homozygous missense variant (p.Gly425Arg) in a patient with intellectual disability, seizures, microcephaly, osteopenia, mild reticulin fibrosis of the bone marrow, and transient neutropenia 9 .
We evaluated three siblings, born to consanguineous parents, for a phenotype of SCN, anemia, thrombocytopenia, reticulin fibrosis of the bone marrow, dysmorphic facial features, osteopenia, hypertriglyceridemia, hepatomegaly, microphthalmia, and optic nerve hypoplasia (Figure 1 A-E). Bone marrow examination revealed trilineage hematopoiesis without maturation arrest ( Figure S1 ).
Myelofibrosis was documented as early as 4 weeks of age and was progressive and severe (Figures S1 and S2). The proband (patient VI.2) had complete 46,XY male-to-female sex reversal and died at age 20 months after multiple infections. At autopsy, she was found to have extensive extramedullary hematopoiesis. The other two affected siblings (patients VI.3, and VI.4) are currently ages 9 and 5 years.
They underwent unrelated-donor bone marrow or stem cell transplantation at 8 and 6.5 months of age, respectively. Post-transplantation bone marrow examinations have shown a reduction in myelofibrosis ( Figure 1F ) and their circulating blood counts have remained normal ( Figure S3 ). Both have severe intellectual disability, are non-ambulatory and non-verbal. The clinical presentation is detailed in Table   1, Figures S1-S3, and Table S1 .
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The parents and a fourth sibling (patient VI.5), who is currently seven months of age, have no neurologic or ophthalmologic abnormalities. The fourth sibling had transient neonatal thrombocytopenia and anemia, and has persistent, mild neutropenia ( Figure S4 ). The mother has had chronic moderate thrombocytopenia, an elevated immature platelet fraction, and peripheral blood smear with macrothrombocytes among variably-sized platelets. These findings have been interpreted as consistent with immune thrombocytopenia. Her CBC is otherwise normal. The father's CBC is normal.
Whole-exome sequencing on the proband (patient VI.2) revealed a variant (NM_022340.3:c.289G>C; NP_001289307.1:p.Gly97Arg) in RBSN, the gene encoding rabenosyn-5, which was homozygous in the three affected children, heterozygous in each parent and patient VI.5, and predicted to affect mRNA splicing and protein function ( Figures S5 and S6A ).
To assess splicing, we sequenced cDNA libraries from the proband (patient VI.2) and the father.
Normally-spliced transcripts were not observed in the proband and represented 45% of transcripts in the father. The most common abnormal transcripts had skipping of exon 5 or an alternative exon 5a ( Figure   S7 ). High-throughput RNA sequencing confirmed these observations and revealed abnormally spliced transcripts that retain exon 5 and its neighboring introns ( Figure S6B ).
Immunoblotting showed an absence of intact rabenosyn-5 in the affected patients ( Figure S6C ).
Immunofluorescence staining revealed larger, clustered EEA1-positive endosomes in patient fibroblasts compared to controls ( Figure S6D ). These findings suggest that the absence of intact rabenosyn-5 affects the structure and function of early endosomes.
For personal use only. on August 9, 2018. by guest www.bloodjournal.org From Transferrin uptake and recycling assays revealed quantitative and qualitative differences in cells from the affected patients compared to those from a healthy control. After 30 minutes of uptake, transferrin was localized to a more clustered perinuclear region in cells from the affected patient ( Figure S6E ). In addition, total transferrin accumulation was higher, and the washout phase was delayed, in cells from the affected patient ( Figure S6F ). These findings are consistent with a decreased rate of recycling of the transferrin receptor and increased steady-state intracellular accumulation of the ligand in cells harboring the RBSN variant. The perinuclear clustering and the increased transferrin accumulation were reversed in cells transfected with a version of the human RBSN gene that does not have the variant ( Figure S8 ).
Our observations suggest that RBSN loss of function causes a severe syndromic form of congenital myelofibrosis, and they confirm that rabenosyn-5 plays a vital role in human development and hematopoiesis. The mechanisms by which RBSN loss of function leads to hematologic and developmental abnormalities are unknown. As previously suggested for VPS45, the neutropenia may result from apoptosis induced by the toxic effects of impaired endosomal trafficking 5, 7 . It is important to note, however, that other congenital disorders associated with increased neutrophil apoptosis, such as pathogenic variants in ELANE, do not also result in congenital myelofibrosis. Thus, additional factors must be at play. One hypothesis is that the myelofibrosis results from impaired trafficking of α-granules and their release from megakaryocytes, resulting in a pro-inflammatory, profibrotic response. Also, given that RBSN loss of function is predicted to result in a reduction of β1 integrin expression at the cell surface, as observed for VPS45 deficiency 5 , it is tempting to speculate that the optic pathway and other central nervous system effects are the result of abnormal axonal transport of integrin transmembrane proteins during development.
For personal use only. on August 9, 2018. by guest www.bloodjournal.org From The phenotypic overlap between our patients and those with mutation affecting VPS45 5-8 suggests the existence of a distinct disorder of early endocytosis caused by pathogenic variants in the genes encoding either member of the rabenosyn-5/VPS45 complex. SCN without maturation arrest, reticulin fibrosis of the bone marrow, and extramedullary hematopoiesis appear to be the hallmarks of the disease. Anemia and thrombocytopenia in our patients were variable and exacerbated by infection and progressive hepatosplenomegaly (Table S1 and Figure S3 ). Long-term survival without substantial hematologic or The structural and phenotypic effects of the variant we report are considerably more severe than those of the previously reported RBSN variant (p.Gly425Arg) 9 . In that patient, intact rabenosyn-5 was detected by immunoblot, the sub-cellular localization of the protein by immunofluorescence staining was normal, and transferrin endocytosis and recycling assays showed a significantly enhanced rate of recycling suggestive of a gain-of-function effect. However, the phenotypic overlap with our patients suggests that the p.Gly425Arg variant is also pathogenic, leading to a milder phenotype within the same spectrum. 
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